April 28, 2025 Delgocitinib Cream Outperforms Alitretinoin in Trial Topical delgocitinib improved eczema severity scores and caused fewer adverse events than oral alitretinoin in adults with severe chronic hand eczema, according to a phase 3 study. Conexiant
April 29, 2025 AACR 2025: Pretrained AI Models Could Help Accurately Diagnose Nonmelanoma Skin Cancers in Resource-Limited Settings The ASCO Post
April 29, 2025 AACR 2025: Pretrained AI Models Could Help Accurately Diagnose Nonmelanoma Skin Cancers in Resource-Limited Settings The ASCO Post
May 27, 2021 Study Finds Adjuvant Immunotherapy of Benefit to Patients With Stage IIB/C Melanoma The ASCO Post
April 17, 2023 Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma The ASCO Post
June 23, 2023 SWOG S1512 Trial: Pembrolizumab Achieves High Response Rates in Rare Type of Melanoma The ASCO Post
April 26, 2024 New Social Media Trend Involving Freckle Tattoos May Conceal Early Signs of Skin Cancer Conexiant
April 01, 2025 Enhancing Practice Performance: Challenges of Problem Solving & Decision Making Ophthalmology Management